Abingdon Health PLC (LSE:ABDX) - Share price


Stock Report

Abingdon Health PLC ABDX

Last Price
GBX55.00

Day Change
1.00|1.85%

As of 05/05/2021
16:28:42 BST | GBX
Minimum 15 Minutes Delay.

Last Close54.00p
Day Range52.00 - 57.00
Mkt Cap51.68Mil
52-Wk Range41.50 - 136.65
Yield %-
ISINGB00BLF79J41
Volume508,587
P/E-
P/S0.10
P/CF0.25

Share Price

Total Returns 05/05/2021

 Chg (%)  
More ...
Abingdon Health PLC-35.29 
FTSE 100 TR GBP4.75
 
Financials
201820192020
More ...
Income Statement
Turnover-2.285.24
Operating Profit--1.40-3.31
Net Profit--1.26-3.37
Reported EPS--1.32-3.53
Balance Sheet
Current Assets1.702.247.18
Non Current Assets5.225.093.79
Total Assets6.927.3310.97
Current Liabilities0.650.856.99
Total Liabilities---
Total Equity5.816.092.75
Cash Flow
Operating Cash Flow--1.441.89
Net Change in Cash-0.393.52
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
06/04/2021PurchaseMs. Melanie Ross93.455,3384,988.00

Company Profile

Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in the healthcare sector and other industries. The company's product, AbC-19, an antibody test for Covid-19 indicating whether a person is generating IgG antibodies to the spike protein of the SARS-CoV-2 virus. Also, the company produces lateral flow tests covering areas such as self-test HIV, equine infection, human fertility, blood cancer and other infectious diseases.

Sector

Diagnostics & Research

Index

Next Event 31/08/2021

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-83.14
Op Mrgn-0.63
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive Director, ChairmanDr. Christopher William Hand
Executive Director, Chief Executive OfficerMr. Chris Henry Francis Yates
Executive Director, Chief Financial OfficerMs. Melanie Ross
Company SecretaryMr. Scott Andrew Page
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2021 Morningstar. All rights reserved.